Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.

Curcio M, Avena P, Cirillo G, Casaburi I, Spizzirri UG, Nicoletta FP, Iemma F, Pezzi V.

Pharm Res. 2020 Feb 14;37(3):55. doi: 10.1007/s11095-020-2775-4.

PMID:
32060727
2.

Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy.

Parisi OI, Ruffo M, Malivindi R, Vattimo AF, Pezzi V, Puoci F.

Pharmaceutics. 2020 Jan 3;12(1). pii: E41. doi: 10.3390/pharmaceutics12010041.

3.

Editorial: Cholesterol and Oxysterols as Signal Molecules in Human Pathophysiology and Cancer: Implications for New Therapeutic Strategies.

Sirianni R, Umetani M, Pezzi V.

Front Endocrinol (Lausanne). 2019 Oct 23;10:732. doi: 10.3389/fendo.2019.00732. eCollection 2019. No abstract available.

4.

In vitro anti-proliferative and anti-bacterial properties of new C7 benzoate derivatives of pinocembrin.

Cappello AR, Aiello F, Polerà N, Armentano B, Casaburi I, Di Gioia ML, Loizzo MR, Dolce V, Pezzi V, Tundis R.

Nat Prod Res. 2019 Jul 16:1-9. doi: 10.1080/14786419.2019.1641805. [Epub ahead of print]

PMID:
31311327
5.

Olea europaea L. Flowers as a new promising anticancer natural product: phenolic composition, antiproliferative activity and apoptosis induction.

Essafi Rhouma H, Trabelsi N, Chimento A, Benincasa C, Tamaalli A, Perri E, Zarrouk M, Pezzi V.

Nat Prod Res. 2019 Jul 8:1-4. doi: 10.1080/14786419.2019.1637867. [Epub ahead of print]

PMID:
31282742
6.

Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol.

Chimento A, De Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, Saturnino C, Pezzi V.

Int J Mol Sci. 2019 Mar 19;20(6). pii: E1381. doi: 10.3390/ijms20061381. Review.

7.

Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer.

De Amicis F, Chimento A, Montalto FI, Casaburi I, Sirianni R, Pezzi V.

Int J Mol Sci. 2019 Mar 3;20(5). pii: E1087. doi: 10.3390/ijms20051087. Review.

8.

Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.

Chimento A, Casaburi I, Avena P, Trotta F, De Luca A, Rago V, Pezzi V, Sirianni R.

Front Endocrinol (Lausanne). 2019 Jan 21;9:807. doi: 10.3389/fendo.2018.00807. eCollection 2018. Review.

9.

Catalytic Double Cyclization Process for Antitumor Agents against Breast Cancer Cell Lines.

Mancuso R, Ziccarelli I, Chimento A, Marino N, Della Ca' N, Sirianni R, Pezzi V, Gabriele B.

iScience. 2018 May 25;3:279-288. doi: 10.1016/j.isci.2018.04.022. Epub 2018 May 3.

10.

Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment.

Casaburi I, Chimento A, De Luca A, Nocito M, Sculco S, Avena P, Trotta F, Rago V, Sirianni R, Pezzi V.

Front Endocrinol (Lausanne). 2018 Sep 11;9:525. doi: 10.3389/fendo.2018.00525. eCollection 2018. Review.

11.

Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions.

Parisi OI, Scrivano L, Amone F, Malivindi R, Ruffo M, Vattimo AF, Pezzi V, Puoci F.

J Funct Biomater. 2018 Jul 12;9(3). pii: E44. doi: 10.3390/jfb9030044.

12.

GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway.

Casaburi I, Avena P, De Luca A, Sirianni R, Rago V, Chimento A, Trotta F, Campana C, Rainey WE, Pezzi V.

Oncotarget. 2017 Dec 14;8(70):115609-115619. doi: 10.18632/oncotarget.23314. eCollection 2017 Dec 29.

13.

Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.

De Luca A, Avena P, Sirianni R, Chimento A, Fallo F, Pilon C, Casaburi I, Pezzi V.

Cells. 2017 Nov 7;6(4). pii: E42. doi: 10.3390/cells6040042.

14.

Calabrian Goji vs. Chinese Goji: A Comparative Study on Biological Properties.

Ruffo M, Parisi OI, Amone F, Malivindi R, Gorgoglione D, De Biasio F, Scrivano L, Pezzi V, Puoci F.

Foods. 2017 Apr 10;6(4). pii: E30. doi: 10.3390/foods6040030.

15.

Determination of mercury in hair: Comparison between gold amalgamation-atomic absorption spectrometry and mass spectrometry.

Domanico F, Forte G, Majorani C, Senofonte O, Petrucci F, Pezzi V, Alimonti A.

J Trace Elem Med Biol. 2017 Sep;43:3-8. doi: 10.1016/j.jtemb.2016.09.008. Epub 2016 Sep 29.

PMID:
27769745
16.

Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment.

Chimento A, Sirianni R, Saturnino C, Caruso A, Sinicropi MS, Pezzi V.

Mini Rev Med Chem. 2016;16(9):699-709. Review.

PMID:
26996623
17.

Development of a novel cell based androgen screening model.

Campana C, Rege J, Turcu AF, Pezzi V, Gomez-Sanchez CE, Robins DM, Rainey WE.

J Steroid Biochem Mol Biol. 2016 Feb;156:17-22. doi: 10.1016/j.jsbmb.2015.11.005. Epub 2015 Nov 12.

18.

Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes.

Chimento A, Saturnino C, Iacopetta D, Mazzotta R, Caruso A, Plutino MR, Mariconda A, Ramunno A, Sinicropi MS, Pezzi V, Longo P.

Bioorg Med Chem. 2015 Nov 15;23(22):7302-12. doi: 10.1016/j.bmc.2015.10.030. Epub 2015 Oct 24. Erratum in: Bioorg Med Chem. 2015 Dec 15;23(24):7785.

PMID:
26526741
19.

Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).

Casaburi I, Avena P, De Luca A, Chimento A, Sirianni R, Malivindi R, Rago V, Fiorillo M, Domanico F, Campana C, Cappello AR, Sotgia F, Lisanti MP, Pezzi V.

Oncotarget. 2015 Sep 22;6(28):25135-48. doi: 10.18632/oncotarget.4722.

20.

GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.

Chimento A, Sirianni R, Casaburi I, Zolea F, Rizza P, Avena P, Malivindi R, De Luca A, Campana C, Martire E, Domanico F, Fallo F, Carpinelli G, Cerquetti L, Amendola D, Stigliano A, Pezzi V.

Oncotarget. 2015 Aug 7;6(22):19190-203.

Supplemental Content

Loading ...
Support Center